The effect of Nigella Sativa on sexual dysfunction in menopausal women

Comparative efficacy of placebo and Nigella sativa in treatment of sexual disorders in menopausal women of women general hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201311066246N2

Enrollment

Registered

2013-11-24

Start date

2013-11-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual dysfunction. Sexual dysfunction, not caused by organic disorder or disease

Interventions

Intervention 1: Intervention group: received 300mg sativa nigella oil once a day for three months. Intervention 2: Control: received placebo orally once a day for three months.

Treatment - Drugs

Placebo

Intervention group: received 300mg sativa nigella oil once a day for three months

Control: received placebo orally once a day for three months

Eligibility

Sex/Gender

Female

Age

40 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criterion: menopausal women with sexual dysfunction. Exclusion criteria: women who use HRT, antidepressants or they have history of depression,cardiovascular disorders,liver diseases ,diabetes.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The effect of Nigella Sativa on sexual dysfunction in menopausal women. Timepoint: 3 months after use of drug. Method of measurement: Female Sexual Function Index questionnaire.	—

Secondary

Measure	Time frame
The effect of Nigella Sativa on vasomotor disorders in menopausal women. Timepoint: After 3 months. Method of measurement: Menopause rating scale questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarnaz Nayebzadeh

Women's general hospital, TUMS

f_nayebzadeh@yahoo.com+98 21 8889 7764

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026